Skip to main content

Amlodipine Besylate

NDC 71335-1865 · Bryant Ranch Prepack

Generic nameAmlodipine Besylate
Dosage formTABLET
RouteORAL
Active ingredient(s)AMLODIPINE BESYLATE
Strength10 mg/1
Pharmacologic classCalcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]
Marketing categoryANDA

Packages

71335-1865-0 7 TABLET in 1 BOTTLE, PLASTIC (71335-1865-0)

71335-1865-1 30 TABLET in 1 BOTTLE, PLASTIC (71335-1865-1)

71335-1865-2 90 TABLET in 1 BOTTLE, PLASTIC (71335-1865-2)

71335-1865-3 60 TABLET in 1 BOTTLE, PLASTIC (71335-1865-3)

71335-1865-4 120 TABLET in 1 BOTTLE, PLASTIC (71335-1865-4)

71335-1865-5 100 TABLET in 1 BOTTLE, PLASTIC (71335-1865-5)

71335-1865-6 800 TABLET in 1 BOTTLE, PLASTIC (71335-1865-6)

71335-1865-7 1000 TABLET in 1 BOTTLE, PLASTIC (71335-1865-7)

71335-1865-8 180 TABLET in 1 BOTTLE, PLASTIC (71335-1865-8)

71335-1865-9 10 TABLET in 1 BOTTLE (71335-1865-9)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

71205-596 — Amlodipine besylate, 71205-599 — Amlodipine Besylate, 71335-0218 — AMLODIPINE BESYLATE, 71335-0473 — AMLODIPINE BESYLATE, 71335-0833 — Amlodipine besylate, 71335-0843 — Amlodipine besylate, 71335-0890 — Amlodipine besylate, 71335-0945 — Amlodipine Besylate, 71335-0953 — Amlodipine and Benazepril Hydrochloride, 71335-1278 — Amlodipine besylate, 71335-1887 — AMLODIPINE BESYLATE, 71335-1946 — Amlodipine Besylate and Benazepril Hydrochloride, 71335-2359 — Amlodipine Besylate, 71335-2507 — Amlodipine Besylate, 71335-2634 — Amlodipine Besylate and Benazepril Hydrochloride, 71335-2924 — Amlodipine and Atorvastatin, 71335-3055 — Amlodipine Besylate and Benazepril Hydrochloride, 71335-3067 — Amlodipine Besylate and Benazepril Hydrochloride, 71335-3076 — Amlodipine and Atorvastatin, 71335-3095 — Amlodipine Besylate and Benazepril Hydrochloride, +519 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.